Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.

Saved in:
Bibliographic Details
Title: Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Authors: Stelljes M; University Hospital Münster, Münster, Germany., Middeke JM; University Hospital TU Dresden, Dresden, Germany., Bug G; Goethe University Frankfurt, Frankfurt am Main, Germany., Wagner-Drouet EM; University Hospital Mainz, Mainz, Germany., Müller LP; University Hospital, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Schmid C; Faculty of Medicine, Augsburg University Hospital, Augsburg, Germany., Krause SW; Uniklinikum Erlangen, Erlangen, Germany., Bethge W; University Hospital Tübingen, Tübingen, Germany., Jost E; University Hospital Aachen & Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Aachen, Germany., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Klein SA; University Hospital Mannheim, Mannheim, Germany., Schubert J; Elblandklinikum, Riesa, Germany., Niederland J; Helios Klinikum Berlin-Buch, Klinik für Hämatologie und Zelltherapie, Berlin, Germany., Kaufmann M; Robert-Bosch-Krankenhaus, Stuttgart, Germany., Schäfer-Eckart K; Paracelsus Medizinische Privat-Universität, Klinikum Nürnberg, Germany., Schaich M; Rems-Murr-Klinikum, Winnenden, Germany., Baldauf H; DKMS gemeinnützige GmbH, Tübingen und Dresden, Germany., Stölzel F; University Hospital TU Dresden, Dresden, Germany; University Hospital Schleswig-Holstein, Kiel, Germany., Petzold C; DKMS gemeinnützige GmbH, Tübingen und Dresden, Germany., Röllig C; University Hospital TU Dresden, Dresden, Germany., Alakel N; University Hospital TU Dresden, Dresden, Germany., Steffen B; Goethe University Frankfurt, Frankfurt am Main, Germany., Hauptrock B; University Hospital Mainz, Mainz, Germany., Schliemann C; University Hospital Münster, Münster, Germany., Sockel K; University Hospital TU Dresden, Dresden, Germany., Lang F; Goethe University Frankfurt, Frankfurt am Main, Germany., Kriege O; University Hospital Mainz, Mainz, Germany., Schaffrath J; University Hospital, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Reicherts C; University Hospital Münster, Münster, Germany., Berdel WE; University Hospital Münster, Münster, Germany., Serve H; Goethe University Frankfurt, Frankfurt am Main, Germany., Ehninger G; University Hospital TU Dresden, Dresden, Germany; Cellex Cell Professionals, Cologne, Germany., Schmidt AH; DKMS gemeinnützige GmbH, Tübingen und Dresden, Germany., Bornhäuser M; University Hospital TU Dresden, Dresden, Germany; National Center for Tumor Diseases, Dresden, Germany., Mikesch JH; University Hospital Münster, Münster, Germany., Schetelig J; University Hospital TU Dresden, Dresden, Germany; DKMS gemeinnützige GmbH, Tübingen und Dresden, Germany. Electronic address: johannes.schetelig@ukdd.de.
Corporate Authors: Study Alliance Leukemia and the German Cooperative Transplant Study Group
Source: The Lancet. Haematology [Lancet Haematol] 2024 May; Vol. 11 (5), pp. e324-e335. Date of Electronic Publication: 2024 Apr 04.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2352-3026
DOI:10.1016/S2352-3026(24)00065-6